ArticleMolecular cancer research : MCR2013

ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Feng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.